Allon Therapeutics
Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on developing the first drugs that impact the progression of neurodegenerative diseases. Therapies available today treat only symptoms and have no effect on the course of the diseases.
news

> February 5, 2010
 Allon Therapeutics presenting at BIO CEO conference

> January 26 , 2010
 Pilot clinical trial initiated to evaluate davunetide in tau-pathology dementias

> January 26 , 2010
 Pilot clinical trial initiated to evaluate davunetide in tau-pathology dementias


THE TANGLES PATHWAY TO ALZHEIMERS

Allon’s human clinical trials and animal studies show that davunetide reduces the classic Alzheimer’s “tangles” pathology and also increases memory function.